Wisebot C1 Cognitive Rehabilitation System
The Wisebot C1 from Huaquejing Medical extends the company’s rehabilitation technology platform into cognitive assessment and training. Designed for patients with cognitive impairment following neurological events, the system provides structured evaluation and intervention protocols.
Product Overview
Cognitive dysfunction frequently accompanies stroke and other neurological conditions, affecting memory, attention, executive function, and other mental processes essential for daily living. The Wisebot C1 addresses these rehabilitation needs through an intelligent platform combining assessment and training capabilities.
As part of Huaquejing Medical’s broader rehabilitation solution strategy, the C1 enables facilities to address cognitive recovery alongside motor rehabilitation using the company’s shared technology architecture.
Key Features
Cognitive Assessment: Standardized evaluation protocols measure cognitive function across multiple domains.
Training Programs: Structured cognitive exercises target specific functional areas identified through assessment.
Progress Tracking: Systematic documentation of cognitive improvement supports treatment planning.
Integrated Platform: Compatible with the company’s motor rehabilitation systems for unified care.
Technical Specifications
Designed for post-stroke cognitive recovery, Wisebot C1 targets memory, attention, and executive function through an assessment-plus-training platform approved by NMPA in 2022.
| Parameter | Specification |
|---|---|
| System Type | Cognitive rehabilitation platform |
| Target Functions | Memory, Attention, Executive function |
| Capabilities | Assessment and Training |
| Interface | Interactive digital platform |
| Classification | Class II Medical Device |
Clinical Applications
The Wisebot C1 serves patients experiencing cognitive impairment from:
- Stroke affecting cognitive function
- Traumatic brain injury
- Other neurological conditions impacting cognition
Cognitive rehabilitation is increasingly recognized as essential to full stroke recovery, as mental function impacts independence, safety, and quality of life outcomes.
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Approved | 2022 |
| Europe (CE) | Not Applied | - |
| USA (FDA) | Not Applied | - |
Frequently Asked Questions
What cognitive functions does the Wisebot C1 address?
The system targets multiple cognitive domains commonly affected by neurological conditions, including attention, memory, and executive function, through both assessment and targeted training protocols.
How does cognitive rehabilitation complement motor rehabilitation?
Cognitive function affects motor learning, safety awareness, and ability to participate in rehabilitation programs. Addressing cognitive impairment alongside motor deficits supports broader recovery outcomes.
Is the Wisebot C1 used independently or with therapist supervision?
The system is designed to support therapist-directed cognitive rehabilitation programs, providing structured assessment and training tools while clinical professionals guide overall treatment planning.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.